Capricor Therapeutics, Inc.
CAPR
$8.64
-$0.42-4.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.73M | -33.94M | -30.17M | -24.57M | -25.91M |
| Total Depreciation and Amortization | 561.80K | 534.70K | 502.60K | 494.70K | 486.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.72M | 6.19M | 7.26M | 4.38M | 3.63M |
| Change in Net Operating Assets | 1.97M | -2.04M | -1.16M | 5.70K | 1.67M |
| Cash from Operations | -31.49M | -29.25M | -23.57M | -19.69M | -20.12M |
| Capital Expenditure | -5.90M | -10.75M | -5.12M | -4.01M | -1.45M |
| Sale of Property, Plant, and Equipment | 92.50K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42.95M | -143.89M | 48.21M | 19.96M | 16.00M |
| Cash from Investing | -48.76M | -154.64M | 43.09M | 15.95M | 14.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.10M | 1.47M | 248.82M | 7.00K | 19.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.34M | -- | -- | -- | -- |
| Cash from Financing | -4.24M | 1.47M | 248.82M | 7.00K | 19.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.49M | -182.43M | 268.34M | -3.73M | -5.55M |